Simone Feiler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Darmstadt, November 25, 2022: The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany. "Mutations in the target gene (MP gene) can affect the diagnostic ...

Darmstadt, November 25, 2022 – The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly h...

Darmstadt, July 19, 2022 – As a fully integrated solution, the new and completely automated RIDA®UNITY system combines sample extraction, PCR setup, real-time PCR and result evaluation in a common workflow...

The quality management system of the biotechnology company complies with the European in-vitro Diagnostic...

Darmstadt, Germany, June 1, 2022 / News Aktuell – R-Biopharm AG, a leading and globally operating...